GLOBAL BLOOD THERAPEUTICS Stock News

ALLEEN STRIKT VOOR EUROPESE MEDISCHE EN FARMACEUTISCHE HANDELSMEDIA Veel patiënten met SCD leven pas in de veertig en doorstaan onvoorspelbare pijncri

Orca Bio raised $192 million from Lightspeed Venture Partners and an unnamed investor for its experimental cell therapy platform.

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Xenetic Biosciences

STRICTLY FOR EUROPEAN MEDICAL AND PHARMACEUTICAL TRADE MEDIA ONLY Many patients with SCD only live into their 40s and endure unpredictable pain crises

In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to Iovance Biotherapeutics (IOVA – Research Report),

A sickle cell advocacy group, Cells of a Generation, COAG has called on the Federal Government to re-evaluate the National Sickle

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –

Stocks Analysis by Zacks Investment Research covering: Apple Inc, Aytu BioScience Inc, Akcea Therapeutics Inc, Axcella Health Inc. Read Zacks Investment Research's latest article on Investing.com

FORMER Strictly Come Dancing judge Arlene Phillips thinks the show made a fuss out of same sex dancers needlessly. The choreographer, 77, told how she had often worked with same sex pairings and cr…

When looking for the best stocks to buy and watch, focus on those with rising relative price strength. One stock that fits that bill is Global Blood Therapeutic, which had its Relative Strength (RS)

99.5% reduction in annualized rate of vaso-occlusive crises (VOC) and acute chest syndrome (ACS) in Group C patients with a history of VOCs and ACS (n=14) who had at least six months follow-upAt up…